Biomedicines,
Journal Year:
2023,
Volume and Issue:
11(8), P. 2092 - 2092
Published: July 25, 2023
The
process
of
memory
entails
the
activation
numerous
neural
networks
and
biochemical
pathways
throughout
brain.
phenomenon
decline
in
relation
to
aging
has
been
subject
extensive
research
for
several
decades.
correlation
between
is
intricate
various
aspects
consider.
Throughout
process,
there
are
alterations
that
take
place
within
brain
and,
as
expected,
affect
other
functions
have
already
linked
its
function
such
involving
microcirculation
sleep.
Recent
studies
provide
an
understanding
how
these
mechanisms
may
be
interconnected
through
relatively
new
concept
glymphatic
system.
system
strongly
correlated
sleep
processes.
Sleep
helps
remove
waste
solutes.
Astrocytes
expand
contract
form
channels
cerebrospinal
fluid
(CSF)
wash
eliminate
waste.
However,
details
not
totally
elusive,
but
discovery
what
we
call
enables
us
connect
many
pieces
physiology
understand
factors
interplay
them.
Thus,
purpose
this
review
discuss
system,
sleep,
memory,
a
network
complex
dynamic
interactions.
Making
inferences
about
the
computations
performed
by
neuronal
circuits
from
synapse-level
connectivity
maps
is
an
emerging
opportunity
in
neuroscience.
The
mushroom
body
(MB)
well
positioned
for
developing
and
testing
such
approach
due
to
its
conserved
architecture,
recently
completed
dense
connectome,
extensive
prior
experimental
studies
of
roles
learning,
memory,
activity
regulation.
Here,
we
identify
new
components
MB
circuit
Drosophila,
including
visual
input
output
neurons
(MBONs)
with
direct
connections
descending
neurons.
We
find
unexpected
structure
sensory
inputs,
transfer
information
different
modalities
MBONs,
modulation
that
dopaminergic
(DANs).
provide
insights
into
circuitry
used
integrate
outputs,
between
central
complex
inputs
DANs,
feedback
MBONs.
Our
results
a
foundation
further
theoretical
work.
Frontiers in Systems Neuroscience,
Journal Year:
2022,
Volume and Issue:
16
Published: March 24, 2022
Synthetic
biology
and
bioengineering
provide
the
opportunity
to
create
novel
embodied
cognitive
systems
(otherwise
known
as
minds)
in
a
very
wide
variety
of
chimeric
architectures
combining
evolved
designed
material
software.
These
advances
are
disrupting
familiar
concepts
philosophy
mind,
require
new
ways
thinking
about
comparing
truly
diverse
intelligences,
whose
composition
origin
not
like
any
available
natural
model
species.
In
this
Perspective,
I
introduce
TAME-Technological
Approach
Mind
Everywhere-a
framework
for
understanding
manipulating
cognition
unconventional
substrates.
TAME
formalizes
non-binary
(continuous),
empirically-based
approach
strongly
agency.
provides
way
think
animal
sentience
an
instance
collective
intelligence
cell
groups,
arising
from
dynamics
that
manifest
similar
numerous
other
When
applied
regenerating/developmental
systems,
suggests
perspective
on
morphogenesis
example
basal
cognition.
The
deep
symmetry
between
problem-solving
anatomical,
physiological,
transcriptional,
3D
(traditional
behavioral)
spaces
drives
specific
hypotheses
by
which
capacities
can
increase
during
evolution.
An
important
medium
exploited
evolution
joining
active
subunits
into
greater
agents
is
developmental
bioelectricity,
implemented
pre-neural
use
ion
channels
gap
junctions
scale
up
cell-level
feedback
loops
anatomical
homeostasis.
This
architecture
multi-scale
competency
biological
has
implications
plasticity
bodies
minds,
greatly
potentiating
evolvability.
Considering
classical
recent
data
perspectives
computational
science,
evolutionary
biology,
cognition,
reveals
rich
research
program
with
many
regenerative
medicine,
artificial
intelligence.
Molecular Psychiatry,
Journal Year:
2023,
Volume and Issue:
28(8), P. 3207 - 3219
Published: June 27, 2023
Tremendous
strides
have
been
made
in
our
understanding
of
the
neurobiological
substrates
memory
-
so-called
"engram".
Here,
we
integrate
recent
progress
engram
field
to
illustrate
how
neurons
transform
across
"lifespan"
a
from
initial
encoding,
consolidation
and
retrieval,
ultimately
forgetting.
To
do
so,
first
describe
cell-intrinsic
properties
shape
emergence
at
encoding.
Second,
highlight
these
encoding
preferentially
participate
synaptic-
systems-level
memory.
Third,
changes
during
guide
neural
reactivation
facilitate
recall.
Fourth,
mechanisms
forgetting,
can
counteract
established
consolidation,
retrieval.
Motivated
by
experimental
results
four
sections,
conclude
proposing
some
conceptual
extensions
traditional
view
engram,
including
broadening
cell-type
participation
within
engrams
stages.
In
collection,
review
synthesizes
general
principles
stages,
describes
future
avenues
further
understand
dynamic
engram.
APL Machine Learning,
Journal Year:
2024,
Volume and Issue:
2(2)
Published: May 9, 2024
Artificial
neural
networks
(ANNs)
have
emerged
as
an
essential
tool
in
machine
learning,
achieving
remarkable
success
across
diverse
domains,
including
image
and
speech
generation,
game
playing,
robotics.
However,
there
exist
fundamental
differences
between
ANNs’
operating
mechanisms
those
of
the
biological
brain,
particularly
concerning
learning
processes.
This
paper
presents
a
comprehensive
review
current
brain-inspired
representations
artificial
networks.
We
investigate
integration
more
biologically
plausible
mechanisms,
such
synaptic
plasticity,
to
improve
these
networks’
capabilities.
Moreover,
we
delve
into
potential
advantages
challenges
accompanying
this
approach.
In
review,
pinpoint
promising
avenues
for
future
research
rapidly
advancing
field,
which
could
bring
us
closer
understanding
essence
intelligence.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: May 24, 2024
Alois
Alzheimer
described
the
first
patient
with
Alzheimer’s
disease
(AD)
in
1907
and
today
AD
is
most
frequently
diagnosed
of
dementias.
a
multi-factorial
neurodegenerative
disorder
familial,
life
style
comorbidity
influences
impacting
global
population
more
than
47
million
projected
escalation
by
2050
to
exceed
130
million.
In
USA
demographic
encompasses
approximately
six
individuals,
expected
increase
surpass
13
2050,
antecedent
phase
AD,
recognized
as
mild
cognitive
impairment
(MCI),
involves
nearly
12
individuals.
The
economic
outlay
for
management
AD-related
decline
estimated
at
355
billion
USD.
addition,
intensifying
prevalence
cases
countries
modest
intermediate
income
further
enhances
urgency
therapeutically
cost-effective
treatments
improving
quality
patients
their
families.
This
narrative
review
evaluates
pathophysiological
basis
an
initial
focus
on
therapeutic
efficacy
limitations
existing
drugs
that
provide
symptomatic
relief:
acetylcholinesterase
inhibitors
(AChEI)
donepezil,
galantamine,
rivastigmine,
N-methyl-D-aspartate
receptor
(NMDA)
allosteric
modulator,
memantine.
hypothesis
amyloid-β
(Aβ)
tau
are
appropriate
targets
have
potential
halt
progress
critically
analyzed
particular
clinical
trial
data
anti-Aβ
monoclonal
antibodies
(MABs),
namely,
aducanumab,
lecanemab
donanemab.
challenges
dogma
targeting
Aβ
will
benefit
majority
subjects
MABs
unlikely
be
“magic
bullet”.
A
comparison
benefits
disadvantages
different
classes
forms
determining
new
directions
research
alternative
drug
undergoing
pre-clinical
assessments.
we
discuss
stress
importance
treatment
co-morbidities,
including
hypertension,
diabetes,
obesity
depression
known
risk
developing
AD.
Molecular Neurodegeneration,
Journal Year:
2021,
Volume and Issue:
16(1)
Published: April 29, 2021
Abstract
Alzheimer’s
disease
(AD)
is
a
progressive,
neurodegenerative
disorder
that
characterized
by
neurodegeneration,
cognitive
impairment,
and
an
eventual
inability
to
perform
daily
tasks.
The
etiology
of
complex,
with
numerous
environmental
genetic
factors
contributing
the
disease.
Late-onset
AD
highly
heritable
(60
80%),
over
40
risk
loci
for
have
been
identified
via
large
genome-wide
association
studies,
most
which
are
common
variants
small
effect
sizes.
Although
these
discoveries
provided
novel
insight
on
biological
contributors
AD,
disease-modifying
treatments
remain
elusive.
Recently,
concepts
resistance
pathology
resilience
against
downstream
consequences
particular
interest
in
field
as
studies
continue
identify
individuals
who
evade
even
into
late
life
all
neuropathological
features
but
neurodegeneration
impairment.
It
has
hypothesized
shift
focus
from
presents
opportunity
uncover
mechanisms
promising
therapeutic
targets
This
review
will
highlight
selection
genes
reported
confer
protection
within
literature
also
discuss
evidence
underpinnings
behind
their
protective
involved
lipid
metabolism,
cellular
trafficking,
endosomal
lysosomal
function,
synaptic
inflammation.
Finally,
we
offer
some
recommendations
areas
where
can
rapidly
advance
towards
precision
interventions
leverage
ideas
development
strategies.